No abstract available
Plain language summary
This cross-sectional study assesses risk of dermatological immune-related adverse events associated with immunotherapy for cancer.
MeSH terms
-
Aged
-
B7-H1 Antigen / antagonists & inhibitors
-
Carcinoma, Squamous Cell* / drug therapy
-
Carcinoma, Squamous Cell* / pathology
-
Female
-
Humans
-
Immune Checkpoint Inhibitors* / adverse effects
-
Immune Checkpoint Inhibitors* / therapeutic use
-
Keratoacanthoma* / diagnosis
-
Keratoacanthoma* / drug therapy
-
Keratoacanthoma* / pathology
-
Male
-
Middle Aged
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Skin Neoplasms* / diagnosis
-
Skin Neoplasms* / drug therapy
-
Skin Neoplasms* / pathology